KIR Genes
The first KIRs to be defined were inhibitory receptors, and when initially coined the acronym stood for 'Killer-cell Inhibitory Receptor'. With appreciation that this family of molecules included both activating and inhibitory receptors, the KIR acronym was retained and is now accepted as an abbreviation for Killer-cell Immunoglobulin-like Receptor (1). Unlike HLA genes, which for practical and historical reasons are named by the WHO Nomenclature Committee for Factors of the HLA System, the naming of KIR genes is the responsibility of the HUGO Genome Nomenclature Committee (HGNC) (2).
The names given to the KIR genes are based on the structures of the molecules they encode. The first digit following the KIR acronym corresponds to the number of Ig-like domains in the molecule, and the 'D' denotes 'domain'. The D is followed by either an 'L' indicating a 'Long' cytoplasmic tail, an 'S' indicating a 'Short' cytoplasmic tail, or a 'P' for pseudogenes. The final digit indicates the number of the gene encoding a protein with this structure. Thus KIR2DL1, KIR2DL2 and KIR2DL3 all encode receptors having two extracellular Ig-like domains and a long cytoplasmic tail (3).
Where two or more genes have very similar structures and have very similar sequences, they may be given the same number but distinguished by a final letter: for example, the KIR2DL5A and KIR2DL5B genes (4). The similarity of these two genes suggests they are related by a recent gene duplication event.
KIR Gene Names
| Gene Symbol | Protein Symbol | Description | Aliases |
|---|---|---|---|
| KIR2DL1 | KIR2DL1 | killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 1 | 47.11, CD158a, cl-42, nkat1, p58.1 |
| KIR2DL2 | KIR2DL2 | killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 2 | CD158b1, cl-43, nkat6 |
| KIR2DL3 | KIR2DL3 | killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 3 | CD158b2, cl-6, nkat2, nkat2a, nkat2b, p58 |
| KIR2DL4 | KIR2DL4 | killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 4 | 15.212, 103AS, CD158d |
| KIR2DL5A | KIR2DL5A | killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 5A | CD158f, KIR2DL5.1 |
| KIR2DL5B | KIR2DL5B | killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 5B | KIR2DL5.2, KIR2DL5.3, KIR2DL5.4 |
| KIR2DS1 | KIR2DS1 | killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 1 | CD158h, EB6Actl, EB6Actll |
| KIR2DS2 | KIR2DS2 | killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 2 | 183Actl, CD158j, cl-49, nkat5 |
| KIR2DS3 | KIR2DS3 | killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 3 | nkat7 |
| KIR2DS4 | KIR2DS4 | killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 4 | CD158i, cl-39, KKA3, nkat8 |
| KIR2DS5 | KIR2DS5 | killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 5 | CD158g, nkat9 |
| KIR2DP1 | KIR2DP1 | killer cell immunoglobulin-like receptor, two domains, pseudogene 1 | KIR2DL6, KIR15, KIRY, KIRZ |
| KIR3DL1 | KIR3DL1 | killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1 | AMB11, CD158e1, cl-2, cl-11, KIR, nkat3, NKB1, NKB1B |
| KIR3DL2 | KIR3DL2 | killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2 | CD158k, cl-5, nkat4, nkat4a, nkat4b |
| KIR3DL3 | KIR3DL3 | killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 3 | CD158z, KIR3DL7, KIR44, KIRC1 |
| KIR3DS1 | KIR3DS1 | killer cell immunoglobulin-like receptor, three domains, short cytoplasmic tail, 1 | CD158e2, nkat10 |
| KIR3DP1 | KIR3DP1 | killer cell immunoglobulin-like receptor, three domains, pseudogene, 1 | CD158c, KIR2DS6, KIR3DS2P, KIR48, KIRX |
References
All references are linked to the PubMed abstract where possible.
- Inhibitory MHC class I receptors on NK and T cells: a standard nomenclature.Immunology Today (1996) 17:100 (Abstract)
- Killer-cell Immunoglobulin-like Receptors (KIR) Nomenclature Report, 2002Tissue Antigens (2003) 62:79-86 (Abstract)Immunogenetics (2003) 55:220-226 (Abstract)Human Immunology (2003) 64:648-654 (Abstract)European Journal of Immunogenetics (2003) 30:229-234 (Abstract)Journal of Immunological Methods (2003) 281:1-8
- KIR: diverse, rapidly evolving receptors of innate and adaptive immunity.Annual Review of Immunology (2002) 20:217-51 (Abstract)
- Some human KIR haplotypes contain two KIR2DL5 genes: KIR2DL5A and KIR2DL5B.Immunogenetics (2002) 54:314-9 (Abstract)